Romero Sacoto, Lilia AzucenaRomero Guamán, Víctor Manuel2024-12-032024-12-032024Romero Guamán.V.M.(2024) Calidad de vida en pacientes con enfermedad de Parkinson en el distrito 03D0110BT2024-TEnf-28https://dspace.ucacue.edu.ec/handle/ucacue/18923La Enfermedad de Parkinson es un trastorno neurodegenerativo que afecta significativamente la calidad de vida de los pacientes. Objetivo: determinar la calidad de vida en adultos con Enfermedad de Parkinson. Metodología: estudio no experimental, observacional de corte transversal. Muestra: 98 pacientes con Parkinson. Instrumentos: escala validada PDQ39 que consta de 8 dimensiones con 39 preguntas. Los datos fueron analizados con JAMOVI. Resultados: media de edad 74,9 años, 53% mujeres, 61% vivienda no adaptada, 30% están en estadio 1 de la enfermedad, 74% toman Levodopa. Alta Fiabilidad y Validez con alfa de Cronbach, Omega, confiabilidad compuesta, Lambda y Varianza Media Extraída mayores a 0,8 demuestra alta fiabilidad y validez. La mayoría de las variables indican un riesgo moderado a excepción de estigma y bienestar emocional con riego bajo. No hubo diferencias entre sexo y tipo de vivienda con calidad de vida. La calidad de vida se afecta igual en hombres y mujeres. Conclusiones: media de edad 74,9 años, mayoría mujeres, en estadio 1 de la enfermedad. El instrumento demostró alta validez y confiabilidad, la mayoría de las dimensiones estuvieron moderadamente afectadas, no existen diferencias significativas entre género y calidad de vida y entre tipo de vivienda y calidad de vida.Parkinson's Disease is a neurodegenerative disorder that significantly impacts patients' quality of life. Objective: To determine the quality of life in adults with Parkinson's Disease. Methodology: A non-experimental, observational, cross-sectional study was conducted. Sample: The sample comprised 98 patients with Parkinson's Disease. Instruments: The validated PDQ-39 scale, consisting of 8 dimensions with 39 questions, was used. Data were analyzed using JAMOVI. Results: The average age was 74.9 years; 53% were women, 61% lived in non-adapted housing, 30% were in stage 1 of the disease, and 74% were taking Levodopa. High reliability and validity were demonstrated through Cronbach's alpha, Omega, composite rel iability, Lambda, and Average Extracted Variance, all exceeding 0.8. Most variables indicated a moderate risk, except for stigma and emotional well-being, which showed low risk —no significant differences between observed gender or housing type and quality of life. Quality of life is equally affected in men and women. Conclusions: The mean age was 74.9 years; most were women, and in stage 1 of the disease. The instrument demonstrated high validity and reliability; most dimensions were moderately affected; no significant differences were found between gender and quality of life or between housing type and quality of life. Keywords: quality of life, Parkinson's Disease, prevalence.application/pdf55 páginasspainfo:eu-repo/semantics/openAccessAtribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/deed.esCALIDAD DE VIDA, PARKINSON, PREVALENCIA.info:eu-repo/semantics/article